Autolus Therapeutics Alternatives & Competitors
12 companies similar to Autolus Therapeutics — Focused on the development of precisely targeted, controlled & highly active T c...
Companies similar to Autolus Therapeutics
Adicet Bio, Inc
A biotechnology company discovering and developing first-in-class allogeneic gamma delta C...
Redwood City, United Stat...
Adaptimmune
Designing and delivering cell therapies to transform the lives of people with cancer.
Abingdon, United Kingdom
Adendra Therapeutics
Translating dendritic cell biology into new therapies for cancer and autoimmunity.
London, United Kingdom
3T Biosciences
3T is an immunotherapy company developing next-generation, transformative therapies for br...
South San Francisco, Unit...
Rival Readout
Competing with Autolus Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Bolt Biotherapeutics, Inc.
Plans to develop a novel format for T-cell mediated anti-tumour therapy
Redwood City, United Stat...
Umoja Biopharma
Pioneering advanced immunotherapies to empower the body's innate ability to fight cancer b...
CRISPR Therapeutics
Gene-based medicines for patients with serious diseases
Boston, United States
Brenus Pharma
Next-generation cancer treatment bringing the immune system one step ahead of cancer 🧬🟣
Lyon, France
Be Biopharma
Engineered B cells as medicines
Cambridge, United States
Aspen Neuroscience, Inc.
Developing autologous iPSC-derived cell replacement therapies for Parkinson’s disease and...
La Jolla, United States
Zenas BioPharma
Enabling patients with autoimmune diseases to reimagine life
Waltham, United States
Cabaletta Bio
Engineered T cell therapies designed for the treatment of patients with autoimmune disease...
Philadelphia, United Stat...
About Autolus Therapeutics
Autolus Therapeutics, founded in 2014, is a pioneering company in the Biopharma, Biotechnology, and Pharmaceutical industries. Based in the United Kingdom, the company is renowned for its innovative approach towards cancer treatment, with a clear focus on developing precisely targeted and highly controlled T cell thera...
Development of autologous T cell therapies, Advanced cell programming, Manufacturing of T cells, Clinical trial management, Pipeline products for cancer and autoimmune diseases
Patients with cancer and autoimmune diseases, Healthcare professionals, Investors interested in biotech innovations, Research institutions
CAR T Cell Therapy, T Cell Programming, Cancer Treatment, Autologous T Cell Therapies, Next-generation Therapies, Obe-cel (obecabtagene Autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7, AUTO8, Autoimmune Disease Treatment, Biopharmaceuticals, Therapeutic Pipeline
B2B, B2D
Product Sales, Licensing
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Autolus Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Autolus Therapeutics on 1 Apr 2026. The 12 companies listed here were last checked between 17 Sep 2025 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
